Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes
2018
Introduction
To evaluate the possibility that switching from reference biologic medicines to biosimilars could lead to altered clinical outcomes, including enhanced immunogenicity, compromised safety, or diminished efficacy for patients, a systematic literature review was conducted of all switching studies between related biologics (including biosimilars).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
37
References
112
Citations
NaN
KQI